DexCom Inc
- Last sale
- Nov 12, 2026 · +1.29%
- Market cap
- $30.35B
- 372.95M shares
- Filings
- 1,079
Q3 2026+15.6% FY25 yoy
Q3 2026+45.1% FY25 yoy
Q3 2026+52.0% FY25 yoy
Q3 2026derived+70.8% FY25 yoy
Q3 2026+47.2% FY25 yoy
Q3 2026+51.4% FY25 yoy
- $30.35B
- 30.6×
- 5.9×
- 12.0×
- 3.62%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $4,662,000,000 | reported | |
| FY 2024 | 2024-12-31 | $4,033,000,000 | reported | |
| FY 2023 | 2023-12-31 | $3,622,300,000 | reported | |
| FY 2022 | 2022-12-31 | $2,909,800,000 | reported | |
| FY 2021 | 2021-12-31 | $2,448,500,000 | reported | |
| FY 2020 | 2020-12-31 | $1,926,700,000 | reported | |
| FY 2019 | 2019-12-31 | $1,476,000,000 | reported | |
| FY 2018 | 2018-12-31 | $1,031,600,000 | reported | |
| FY 2017 | 2017-12-31 | $718,500,000 | reported | |
| FY 2016 | 2016-12-31 | $573,300,000 | reported | |
| FY 2015 | 2015-12-31 | $402,000,000 | reported | |
| FY 2014 | 2014-12-31 | $259,200,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $500.00M | $500.00M | — | 384.86M sh | −1.5% | 46.4% |
| FY2024 | — | $750.00M | $750.00M | — | 390.77M sh | +1.4% | 118.9% |
| FY2023 | — | $688.70M | $688.70M | — | 385.52M sh | −0.2% | 134.5% |
| FY2022 | — | $557.70M | $557.70M | — | 386.41M sh | +298.1% | 183.0% |
| FY2021 | — | $0.00 | $0.00 | — | 97.07M sh | +0.9% | 0.0% |
Segments
Geography
LineFY2025ShareChange
United States$3.33B72%+15.4%
International$1.33B28%+16.1%
Total$4.66B
Surgical & medical instruments & apparatus
DexCom Inc is the 9th largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
SOLVSolventum Corp$8.3B0.9%18.7%$15.1BRMDResmed Inc$5.7B9.9%26.9%$33.6B
DXCMDexCom Inc (this company)$4.7B15.6%17.9%$30.4B
MMEDMiniMed Group, Inc.$3.1B14.3%10.7%$5.0BWSTWest Pharmaceutical Services Inc$3.1B6.3%16.1%$28.7BGMEDGlobus Medical Inc$2.9B16.7%18.3%$9.7BPODDInsulet Corp$2.7B30.7%9.1%$10.4BICUIICU Medical Inc$2.2B6.3%0.0%$4.4BTFXTeleflex Inc$2.0B17.2%45.4%$6.1BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
DexCom Inc · CIK 1093557 · Engraved from SEC EDGAR